During the past decade, Klaipeda Seamen's Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klaipeda Seamen's Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klaipeda Seamen's Hospital" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Norwegian Health Association" with 1 trials as a collaborator, "The Royal Norwegian Ministry of Health" with 1 trials as a collaborator and "UiT The Arctic University of Norway" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Klaipeda Seamen's Hospital" are "Ulcerative Colitis" (6 trials), "Atrial Fibrillation" (4 trials), "Acute Myocardial Infarction" (1 trials), "B-cell Lymphoma" (1 trials) and "Chronic B-Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Klaipeda Seamen's Hospital" in a lesser frequency.

Most popular intervention types in "Klaipeda Seamen's Hospital" are "Drug" (19 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (2 trials), "Mirikizumab" (2 trials), "Rituximab" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klaipeda Seamen's Hospital" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Klaipeda Seamen's Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Klaipeda Seamen's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klaipeda Seamen's Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".